These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29202563)

  • 21. Quality of life after radio frequency ablation turbinate reduction (RFATR) among patients with rhinitis medicamentosa & withdrawal from decongestant topical spray abuse.
    Carmel Neiderman NN; Caspi I; Eisenberg N; Halevy N; Wengier A; Shpigel I; Ziv Baran T; Ringel B; Warshavsky A; Abergel A
    Am J Otolaryngol; 2023; 44(4):103842. PubMed ID: 36989755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased frequency of rhinitis medicamentosa due to media advertising for nasal topical decongestants.
    Archontaki M; Symvoulakis EK; Hajiioannou JK; Stamou AK; Kastrinakis S; Bizaki AJ; Kyrmizakis DE
    B-ENT; 2009; 5(3):159-62. PubMed ID: 19902852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Ultrastructural changes in human nasal mucosa in rhinitis medicamentosa].
    Knipping S; Holzhausen HJ; Riederer A; Bloching M
    HNO; 2006 Oct; 54(10):742-8. PubMed ID: 16477462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of Rhinitis Medicamentosa: A Systematic Review.
    Zucker SM; Barton BM; McCoul ED
    Otolaryngol Head Neck Surg; 2019 Mar; 160(3):429-438. PubMed ID: 30325708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rhinitis medicamentosa: a nationwide survey of Canadian otolaryngologists.
    Fowler J; Chin CJ; Massoud E
    J Otolaryngol Head Neck Surg; 2019 Dec; 48(1):70. PubMed ID: 31818321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe Rhinitis Medicamentosa Successfully Treated with Rhinolight® Endonasal UV Phototherapy.
    Carson P; Lyons M
    Ir Med J; 2019 Feb; 112(2):874. PubMed ID: 30875167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rhinitis medicamentosa: aspects of pathophysiology and treatment.
    Graf P
    Allergy; 1997; 52(40 Suppl):28-34. PubMed ID: 9353558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical glucocorticoid reduces the topical decongestant-induced histologic changes in an animal model nasal mucosa.
    Akpinar ME; Yigit O; Akakin D; Sarioz O; Ozkan N; Yildiz SD; Azizli E; Sehirli US
    Laryngoscope; 2012 Apr; 122(4):741-6. PubMed ID: 22374848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should Excess Topical Decongestant Use Raise a Red Flag? Rhinitis Medicamentosa and Opioid Use Disorder.
    Patel A; Levi JR; Brook CD
    Ann Otol Rhinol Laryngol; 2020 Feb; 129(2):164-169. PubMed ID: 31581795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucosal changes in rhinitis medicamentosa.
    Lin CY; Cheng PH; Fang SY
    Ann Otol Rhinol Laryngol; 2004 Feb; 113(2):147-51. PubMed ID: 14994772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rhinitis medicamentosa: a review of causes and treatment.
    Graf P
    Treat Respir Med; 2005; 4(1):21-9. PubMed ID: 15725047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extended use of topical nasal decongestants.
    Yoo JK; Seikaly H; Calhoun KH
    Laryngoscope; 1997 Jan; 107(1):40-3. PubMed ID: 9001263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rhinitis medicamentosa: the forgotten factor in nasal obstruction.
    Mabry RL
    South Med J; 1982 Jul; 75(7):817-9. PubMed ID: 6178170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rhinitis medicamentosa: therapeutic effect of diode laser inferior turbinate reduction on nasal obstruction and decongestant abuse.
    Caffier PP; Frieler K; Scherer H; Sedlmaier B; Göktas O
    Am J Rhinol; 2008; 22(4):433-9. PubMed ID: 18702912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomised trial on performance, safety and clinical benefit of hyaluronic acid, hyaluronic acid plus dexpanthenol and isotonic saline nasal sprays in patients suffering from dry nose symptoms.
    Thieme U; Müller K; Bergmann C; Bock B; Wurzer-Materna N; Shahab T; Zeman F; Eberhardt Y; Huppertz G; Koller M; Meiser P
    Auris Nasus Larynx; 2020 Jun; 47(3):425-434. PubMed ID: 32067777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Daily administration of nose drops can cause chronic nasal congestion].
    Graf P; Hallén H
    Lakartidningen; 1996 Jan; 93(4):259-62. PubMed ID: 8569350
    [No Abstract]   [Full Text] [Related]  

  • 37. Changes in nasal reactivity in patients with rhinitis medicamentosa after treatment with fluticasone propionate and placebo nasal spray.
    Graf PM; Hallén H
    ORL J Otorhinolaryngol Relat Spec; 1998; 60(6):334-8. PubMed ID: 9742282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Medically-induced rhinitis].
    Nosulya EV
    Vestn Otorinolaringol; 2017; 82(3):84-90. PubMed ID: 28631690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained use of xylometazoline nasal spray shortens the decongestive response and induces rebound swelling.
    Graf P; Juto JE
    Rhinology; 1995 Mar; 33(1):14-7. PubMed ID: 7540314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One year follow-up of patients with rhinitis medicamentosa after vasoconstrictor withdrawal.
    Graf PM; Hallén H
    Am J Rhinol; 1997; 11(1):67-72. PubMed ID: 9065350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.